The Drug Administration of Vietnam has issued a decision to resume the export of 37 drugs having been suspended to be reserved for domestic use during the novel coronavirus disease (COVID-19) pandemic.
The decision was signed by Vu Tuan Cuong, head of the administration, on Tuesday.
Vietnam began to cease exporting the aforementioned drugs on April 16, based on a list compiled since March by the Ministry of Health detailing which medicine was necessary for a COVID-19 quarantine and treatment facility.
The list mainly includes painkillers, antipyretics, antibiotics, infusions, and dialysis fluid.
As the situation of the pandemic in Vietnam has improved with only 39 patients remaining in treatment as of Thursday morning, Prime Minister Nguyen Xuan Phuc has recently approved a proposal by the National Steering Committee for COVID-19 Prevention and Control, allowing the export resumption.
Related agencies are requested to ensure the national reserves are sufficient for domestic use after export resumes.
Vietnam has confirmed 271 COVID-19 cases in total, with 232 having recovered and no deaths.